As shown in Figure 1, this inhibition maintains the undifferentiated, highly proliferative neuroendocrine phenotype characteristic of SCLC and is transcriptionally driven by ASCL1, a key regulator of neuroendocrine differentiation [30]. This evidence concerns the gene ASCL1 and small cell lung carcinoma.